Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C et al (2017) 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
FRI483 Changes In Thyroid Function Test With Tirzepatide Use In Patients With Hypothyroidism
All research applications remain confined to laboratory environments and experimental frameworks
And its an important question I explore deeply in my new book, Brain Defenders
Sikiri P, Petek M, Rucman R, Seiwerth S, Grabarevi Z, Rotkvi I, et al
BREAKING: Semaglutide for MASH: A Step Forward in Metabolic Liver Disease Phase 3 data just released (NEJM 2025): In 800 patients with biopsy-confirmed MASH and fibrosis stage 23, semaglutide 2.4 mg weekly delivered impressive results at 72 weeks (compared to placebo): Histologic Outcomes: 63% achieved resolution of steatohepatitis without worsening fibrosis (vs